In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Reproductive Hormones and Proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine functions (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reproductive hormones and proteins tests devices market, including market shares of different players within Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the reproductive hormones and proteins tests market in Norway was F. Hoffmann-La Roche followed by Siemens Healthineers, Danaher, Abbott Laboratories and Quidelortho.
The tests are performed to detect, measure, and monitor the presence of specific Reproductive Hormones and Proteins in a patient’s sample. These devices are employed to examine the reasons for infertility and other menstrual-related complications.
The value of the reproductive hormones and proteins tests devices market within Norway was expected to be over $0.8m in 2023.
For the latest complete market share analysis of reproductive hormones and proteins tests device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
